Part 11/15:
He underscores the importance of demonstrating safety and efficacy in humans, emphasizing that most current therapies are still experimental. Still, the rapid advances in gene editing, regenerative medicine, and biotech startups mean that the age of human rejuvenation could be just over a decade away.
The Ethical Dimensions of Genetic Interventions
An intriguing part of the discussion touches on controversial research like CRISPR editing of human embryos—such as the infamous case in China where scientists edited embryos to confer resistance to HIV. De Grey notes that these experiments raise profound ethical issues, especially given the unpredictable effects and potential for unintended consequences like increased disease risk or cognitive differences.